{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:07:19Z","timestamp":1767650839130,"version":"3.48.0"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,16]]},"DOI":"10.1515\/jbcpp-2022-0206","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T16:53:48Z","timestamp":1668012828000},"page":"1-4","source":"Crossref","is-referenced-by-count":2,"title":["Peyronie\u2019s disease: where are we at?"],"prefix":"10.1515","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-4403","authenticated-orcid":false,"given":"Francesco P.","family":"Calace","sequence":"first","affiliation":[{"name":"Urology Unit, Department of Neurosciences, Reproductive Sciences and Odontostomatology , University of Naples \u201cFederico II\u201d , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Napolitano","sequence":"additional","affiliation":[{"name":"Urology Unit, Department of Neurosciences, Reproductive Sciences and Odontostomatology , University of Naples \u201cFederico II\u201d , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nunzio A.","family":"Langella","sequence":"additional","affiliation":[{"name":"Department of Urology , AORN Antonio Cardarelli , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biagio","family":"Barone","sequence":"additional","affiliation":[{"name":"Urology Unit, Department of Neurosciences, Reproductive Sciences and Odontostomatology , University of Naples \u201cFederico II\u201d , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Trama","sequence":"additional","affiliation":[{"name":"Department of Surgical and Biomedical Science , Andrological and Urogynecological Clinic, Santa Maria Terni Hospital, University of Perugia , Terni , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_001","unstructured":"EAU Guidelines. Edn. presented at the EAU annual congress Amsterdam; 2022."},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_002","doi-asserted-by":"crossref","unstructured":"Al-Thakafi, S, Al-Hathal, N. Peyronie\u2019s disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up. Transl Androl Urol 2016;5:280\u20139. https:\/\/doi.org\/10.21037\/tau.2016.04.05.","DOI":"10.21037\/tau.2016.04.05"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_003","doi-asserted-by":"crossref","unstructured":"El-Sakka, AI, Salabas, E, Din\u00e7er, M, Kadioglu, A. The pathophysiology of peyronie\u2019s disease. Arab J Urol 2013;11:272\u20137. https:\/\/doi.org\/10.1016\/j.aju.2013.06.006.","DOI":"10.1016\/j.aju.2013.06.006"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_004","unstructured":"Crocetto, F, Barone, B, Manfredi, C, Trama, F, Romano, L, Romeo, M, et al.. Are insulin resistance and non-alcoholic fatty liver disease associated with peyronie\u2019s disease? A pilot study. J Physiol Pharmacol 2022;73:1\u201310. https:\/\/doi.org\/10.26402\/jpp.2022.1.05."},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_005","doi-asserted-by":"crossref","unstructured":"Sharma, KL, Alom, M, Trost, L. The etiology of peyronie\u2019s disease: pathogenesis and genetic contributions. Sex Med Rev 2020;8:314\u201323. https:\/\/doi.org\/10.1016\/j.sxmr.2019.06.004.","DOI":"10.1016\/j.sxmr.2019.06.004"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_006","doi-asserted-by":"crossref","unstructured":"Rojo, EG, Garc\u00eda G\u00f3mez, B, Santos-P\u00e9rez de la Blanca, R, Manfredi, C, Alonso Isa, M, Medina Polo, J, et al.. Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in peyronie\u2019s disease: a new diagnostic approach to predict the stage of the disease? Asian J Androl 2021;23:325\u20139. https:\/\/doi.org\/10.4103\/aja.aja_74_20.","DOI":"10.4103\/aja.aja_74_20"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_007","doi-asserted-by":"crossref","unstructured":"Krishnappa, P, Manfredi, C, Sinha, M, Arcaniolo, D, Matippa, P, Moncada, I. Penile modeling in peyronie\u2019s disease: a systematic review of the literature. Sex Med Rev 2022;10:434\u201350. https:\/\/doi.org\/10.1016\/j.sxmr.2022.01.001.","DOI":"10.1016\/j.sxmr.2022.01.001"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_008","doi-asserted-by":"crossref","unstructured":"Nelson, CJ, Mulhall, JP. Psychological impact of peyronie\u2019s disease: a review. J Sex Med 2013;10:653\u201360. https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02999.x.","DOI":"10.1111\/j.1743-6109.2012.02999.x"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_009","doi-asserted-by":"crossref","unstructured":"Illiano, E, Trama, F, Mancini, V, Ruffo, A, Romeo, G, Riccardo, F, et al.. Peyronie\u2019s disease may negatively impact the sexual experience of a couple and female sexual function: a single center study. Transl Androl Urol 2021;10:555\u201362.","DOI":"10.21037\/tau-20-1067"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_010","doi-asserted-by":"crossref","unstructured":"Crocetto, F, Arcaniolo, D, Napolitano, L, Barone, B, La Rocca, R, Capece, M, et al.. Impact of sexual activity on the risk of male genital tumors: a systematic review of the literature. Int J Environ Res Publ Health 2021;18:1\u201316. https:\/\/doi.org\/10.3390\/ijerph18168500.","DOI":"10.3390\/ijerph18168500"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_011","doi-asserted-by":"crossref","unstructured":"Hellstrom, WJG, Feldman, R, Rosen, RC, Smith, T, Kaufman, G, Tursi, J. Bother and distress associated with peyronie\u2019s disease: validation of the peyronie\u2019s disease questionnaire. J Urol 2013;190:627\u201334. https:\/\/doi.org\/10.1016\/j.juro.2013.01.090.","DOI":"10.1016\/j.juro.2013.01.090"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_012","doi-asserted-by":"crossref","unstructured":"Hellstrom, WJG, Feldman, RA, Coyne, KS, Kaufman, GJ, Smith, TM, Tursi, JP, et al.. Self-report and clinical response to peyronie\u2019s disease treatment: peyronie\u2019s disease questionnaire results from 2 large double-blind, randomized, placebo-controlled phase 3 studies. Urology 2015;86:291\u20138. https:\/\/doi.org\/10.1016\/j.urology.2015.04.047.","DOI":"10.1016\/j.urology.2015.04.047"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_013","doi-asserted-by":"crossref","unstructured":"Kel\u00e2mi, A. Classification of congenital and acquired penile deviation. Urol Int 1983;38:229\u201333. https:\/\/doi.org\/10.1159\/000280897.","DOI":"10.1159\/000280897"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_014","doi-asserted-by":"crossref","unstructured":"Trama, F, Illiano, E, Iacono, F, Ruffo, A, di Lauro, G, Aveta, A, et al.. Use of penile shear wave elastosonography for the diagnosis of Peyronie\u2019s Disease: a prospective case-control study. Basic Clin Androl 2022;32:15.","DOI":"10.1186\/s12610-022-00164-w"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_015","doi-asserted-by":"crossref","unstructured":"Tsambarlis, P, Levine, LA. Nonsurgical management of peyronie\u2019s disease. Nat Rev Urol 2019;16:172\u201386. https:\/\/doi.org\/10.1038\/s41585-018-0117-7.","DOI":"10.1038\/s41585-018-0117-7"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_016","doi-asserted-by":"crossref","unstructured":"Rojo, EG, Garc\u00eda G\u00f3mez, B, Manfredi, C, Alonso Isa, M, Medina Polo, J, Carpintero Miguel, M, et al.. Efficacy and safety of dorsal penile nerve block before collagenase of clostridium histolyticum injections in peyronie\u2019s disease patients: results from a prospective pilot study. Andrologia 2020;52:1\u20136. https:\/\/doi.org\/10.1111\/and.13740.","DOI":"10.1111\/and.13740"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_017","doi-asserted-by":"crossref","unstructured":"Palmieri, A, Imbimbo, C, Creta, M, Verze, P, Fusco, F, Mirone, V. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with peyronie\u2019s disease and erectile dysfunction: results from a prospective randomized trial. Int J Androl 2012;35:190\u20135. https:\/\/doi.org\/10.1111\/j.1365-2605.2011.01226.x.","DOI":"10.1111\/j.1365-2605.2011.01226.x"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_018","doi-asserted-by":"crossref","unstructured":"Manfredi, C, Arcaniolo, D, Amicuzi, U, Spirito, L, Napolitano, L, Crocerossa, F, et al.. Impact of extracorporeal shockwave therapy for erectile dysfunction and peyronie\u2019s disease on reproductive and hormonal testicular function. Androl 2022;10:1368\u201375. https:\/\/doi.org\/10.1111\/andr.13240.","DOI":"10.1111\/andr.13240"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_019","doi-asserted-by":"crossref","unstructured":"Russo, GI, Cacciamani, G, Cocci, A, Kessler, TM, Morgia, G, Serefoglu, FC, et al.. Comparative effectiveness of intralesional therapy for peyronie\u2019s disease in controlled clinical studies: a systematic review and network meta-analysis. J Sex Med 2019;16:289\u201399. https:\/\/doi.org\/10.1016\/j.jsxm.2018.12.011.","DOI":"10.1016\/j.jsxm.2018.12.011"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_020","doi-asserted-by":"crossref","unstructured":"Capece, M, Arcaniolo, D, Manfredi, C, Palmieri, A, De Sio, M, Verze, P, et al.. Second cycle of intralesional collagenase clostridium histolyticum for peyronie\u2019s disease using the modified shortened protocol: results from a retrospective analysis. Andrologia 2020;52:1\u20135. https:\/\/doi.org\/10.1111\/and.13527.","DOI":"10.1111\/and.13527"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_021","doi-asserted-by":"crossref","unstructured":"Culha, MG, Erkan, E, Cay, T, Y\u00fcceta\u015f, U. The effect of platelet-rich plasma on peyronie\u2019s disease in rat model. Urol Int 2019;102:218\u201323. https:\/\/doi.org\/10.1159\/000492755.","DOI":"10.1159\/000492755"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_022","doi-asserted-by":"crossref","unstructured":"Asali, M, Asali, M. Intralesional injection of the calcium channel blocker verapamil in peyronie\u2019s disease: a critical review. Arch Ital Urol Androl 2020;92. https:\/\/doi.org\/10.4081\/aiua.2020.3.253.","DOI":"10.4081\/aiua.2020.3.253"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_023","doi-asserted-by":"crossref","unstructured":"Natale, C, McLellan, DM, Yousif, A, Hellstrom, WJG. Review of intralesional collagenase Clostridium histolyticum injection therapy and related combination therapies in the treatment of peyronie\u2019s disease (an update). Sex Med Rev 2021;9:340\u20139. https:\/\/doi.org\/10.1016\/j.sxmr.2020.01.005.","DOI":"10.1016\/j.sxmr.2020.01.005"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_024","doi-asserted-by":"crossref","unstructured":"Cowper, MG, Burkett, CB, Le, TV, Scherzer, N, Hellstrom, WJG. Penile stretching as a treatment for peyronie\u2019s disease: a review. Sex Med Rev 2019;7:508\u201315. https:\/\/doi.org\/10.1016\/j.sxmr.2018.11.002.","DOI":"10.1016\/j.sxmr.2018.11.002"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_025","doi-asserted-by":"crossref","unstructured":"Ragheb, A, Eraky, A, Osmonov, D. A decade of grafting techniques as a sole treatment for peyronie\u2019s disease. Androl 2020;8:1651\u20139. https:\/\/doi.org\/10.1111\/andr.12857.","DOI":"10.1111\/andr.12857"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_026","doi-asserted-by":"crossref","unstructured":"Verze, P, Sokolakis, I, Manfredi, C, Ruvolo, CC, Hatzichristodoulou, G, Romero-Otero, J. Penile prosthesis implant in the management of peyronies\u2019 disease. Minerva Urol Nephrol 2021;73:196\u2013214. https:\/\/doi.org\/10.23736\/S2724-6051.20.03890-4.","DOI":"10.23736\/S2724-6051.20.03890-4"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_027","doi-asserted-by":"crossref","unstructured":"Almeida, JL, Fel\u00edcio, J, Martins, FE. Surgical planning and strategies for peyronie\u2019s disease. Sex Med Rev 2021;9:478\u201387. https:\/\/doi.org\/10.1016\/j.sxmr.2020.07.008.","DOI":"10.1016\/j.sxmr.2020.07.008"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_028","doi-asserted-by":"crossref","unstructured":"Garcia-Gomez, B, Ralph, D, Levine, L, Moncada-Iribarren, I, Djinovic, R, Albersen, M, et al.. Grafts for peyronie\u2019s disease: a comprehensive review. Androl 2018;6:117\u201326. https:\/\/doi.org\/10.1111\/andr.12421.","DOI":"10.1111\/andr.12421"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_029","doi-asserted-by":"crossref","unstructured":"Fiorillo, A, Droghetti, M, Palmisano, F, Bianchi, L, Piazza, P, Sadini, P, et al.. Long-term outcomes after plaque incision and grafting for peyronie\u2019s disease: comparison of porcine dermal and bovine pericardium grafts. Androl 2021;9:269\u201376. https:\/\/doi.org\/10.1111\/andr.12912.","DOI":"10.1111\/andr.12912"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_030","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Pascual, E, Manfredi, C, Torremad\u00e9, J, Ibarra, FP, Geli, JS, Romero-Otero, J, et al.. Multicenter prospective study of grafting with collagen fleece TachoSil in patients with peyronie\u2019s disease. J Sex Med 2020;17:2279\u201386. https:\/\/doi.org\/10.1016\/j.jsxm.2020.07.079.","DOI":"10.1016\/j.jsxm.2020.07.079"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_031","doi-asserted-by":"crossref","unstructured":"Rybak, J, Papagiannopoulos, D, Levine, L. A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for peyronie\u2019s disease: measured lengths and patient perceptions. J Sex Med 2012;9:2396\u2013403. https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02849.x.","DOI":"10.1111\/j.1743-6109.2012.02849.x"},{"key":"2025121209092850059_j_jbcpp-2022-0206_ref_032","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Pascual, E, Manfredi, C, Cocci, A, Quintana Franco, LM, Egui Rojo, MA, Carballido Rodr\u00edguez, J, et al.. A novel penile splint as early traction therapy after grafting techniques for peyronie\u2019s disease. J Sex Med 2020;17:1819\u201324. https:\/\/doi.org\/10.1016\/j.jsxm.2020.05.009.","DOI":"10.1016\/j.jsxm.2020.05.009"}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2022-0206\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2022-0206\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:42:04Z","timestamp":1765539724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2022-0206\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,11,9]]},"published-print":{"date-parts":[[2023,1,16]]}},"alternative-id":["10.1515\/jbcpp-2022-0206"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2022-0206","relation":{},"ISSN":["0792-6855","2191-0286"],"issn-type":[{"type":"print","value":"0792-6855"},{"type":"electronic","value":"2191-0286"}],"subject":[],"published":{"date-parts":[[2022,11,9]]}}}